Evaluating DSLT for Newly Diagnosed Open Angle Glaucoma Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effectiveness of the DSLT procedure in treatment-naïve patients diagnosed with primary open angle glaucoma. The goal is to achieve a significant reduction in intraocular pressure (IOP) without the need for medication over a 12-month period. Eligible participants include those aged 30 and older with mild to moderate glaucoma, who have not received any prior treatment. The study aims to provide insights into how DSLT can help manage glaucoma effectively.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Primary open angle glaucoma
* Patients age 30 or greater with an IOP of 18-26 mmHg
* Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
* DSLT procedure

Exclusion Criteria:

* History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
* Angle closure patients
* Ocular Hypertension
* Baseline VF MD of worse than -12dB
* Uncontrolled systemic microvascular disease (eg. HTN, DM)
* Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

Where it's running

• Barnet Dulaney Perkins Eye Centers
  Mesa, Arizona, United States Recruiting

Study contacts

• Principal investigator: Christine Funke, Medical Doctor — Barnet Dulaney Perkins Eye Centers
• Study coordinator: Derek J Arnson, Master of Education
• Email: derek.arnson@researchavp.com
• Phone: 4804201005

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

  In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

  Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

• iDose TR implant administration in an office-based eye clinic

  This study tests a travoprost implant (iDose TR) given inside the eye to people with open-angle glaucoma or high eye pressure in an office setting to see if it is safe.

  Recruiting Glaukos Corporation · Austin, Texas · NCT07816692

• Brillouin hydration mapping to study cornea health

  Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07780890

• Direct (non-contact) laser versus standard selective laser for treating glaucoma

  This test compares a newer non-contact laser (DSLT) with the standard SLT to see if it lowers eye pressure just as well in adults with open-angle glaucoma or ocular hypertension.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07408154

• Updated inserter for the 75 mcg Travoprost intracameral implant

  This study will see if the new G2-TRIO inserter reliably and safely delivers the 75 mcg Travoprost intracameral implant in adults with open-angle glaucoma or ocular hypertension.

  Recruiting Glaukos Corporation · Kenosha, Wisconsin · NCT07400926

• Cataract surgery with iStent inject versus Kahook Dual Blade goniotomy for open-angle glaucoma

  This trial tests whether adding either two iStent inject implants or a Kahook Dual Blade goniotomy at the time of cataract surgery helps people with open-angle glaucoma lower eye pressure or reduce glaucoma medications.

  Recruiting at 2 sites Medical University of Bialystok · Bialystok, Polska and 1 other locations · NCT07325552

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.